Open-label, randomized, active-controlled study of Levetiracetam (LEV) used as monotherapy in patients with Partial-Onset Seizures - Trial 2015-004586-84

Name: Clinical Trial 2015-004586-84
Creator: UCB Pharma SA
Keywords: Epilepsy, clinical trial

Access comprehensive clinical trial information for 2015-004586-84 through Pure Global AI's free database. This phase not specified trial is sponsored by UCB Pharma SA and is currently status unknown. The study focuses on Epilepsy.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2015-004586-84

Trial Details

EU Clinical Trials Register • 2015-004586-84

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Open-label, randomized, active-controlled study of Levetiracetam (LEV) used as monotherapy in patients with Partial-Onset Seizures

Study Focus

Disease/Condition

Epilepsy

Sponsor & Location

Primary Sponsor

UCB Pharma SA

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

ICD-10 Classifications

Epilepsy

Epilepsy, unspecified

Other epilepsy

Status epilepticus

Other status epilepticus

Data Source

Registry

EU Clinical Trials Register

Trial ID

2015-004586-84

Type

Non-Device Trial